Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul-Su Yang

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Microbial Cell (Graz, Austria)|March 31, 2017
Advancing host-directed therapy for tuberculosisChul-Su Yang
Microbial Cell (Graz, Austria)|November 29, 2018
Protective roles of ginseng against bacterial infectionYe-Ram Kim, Chul-Su Yang
Journal of Microbiology and Biotechnology|July 7, 2017
Host-Directed Therapeutics as a Novel Approach for Tuberculosis TreatmentYe-Ram Kim, Chul-Su Yang
Science Advances|May 8, 2026
Targeting cGAS-STING signaling to overcome antibiotic-resistant bacterial infections: Challenges and opportunitiesYu Seong Ham, Minseo Jeong, Chul-Su Yang
Journal of Microbiology and Biotechnology|October 4, 2019
Latest Comprehensive Knowledge of the Crosstalk between TLR Signaling and Mycobacteria and the Antigens Driving the ProcessJae-Sung Kim, Ye-Ram Kim, Chul-Su Yang
International Neurourology Journal|April 14, 2012
The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory DiseasesChul-Su Yang, Dong-Min Shin, Eun-Kyeong Jo
Immune Network|January 29, 2010
The role of nitric oxide in mycobacterial infectionsChul-Su Yang, Jae-Min Yuk, Eun-Kyeong Jo
Frontiers in Immunology|September 9, 2020
Host-Directed Therapy in Tuberculosis: Targeting Host MetabolismJae-Sung Kim, Ye-Ram Kim, Chul-Su Yang
Frontiers in Immunology|November 7, 2022
The strategies of NLRP3 inflammasome to combat <i>Toxoplasma gondii</i>Chanjin Yoon, Yu Seong Ham, Woo Jin Gil, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2022
Pathogen-derived peptides in drug targeting and its therapeutic approachSeok-Jun Mun, Euni Cho, Jae-Sung Kim, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Microbial Cell (Graz, Austria)|March 31, 2017
Advancing host-directed therapy for tuberculosisChul-Su Yang
Microbial Cell (Graz, Austria)|November 29, 2018
Protective roles of ginseng against bacterial infectionYe-Ram Kim, Chul-Su Yang
Journal of Microbiology and Biotechnology|July 7, 2017
Host-Directed Therapeutics as a Novel Approach for Tuberculosis TreatmentYe-Ram Kim, Chul-Su Yang
Science Advances|May 8, 2026
Targeting cGAS-STING signaling to overcome antibiotic-resistant bacterial infections: Challenges and opportunitiesYu Seong Ham, Minseo Jeong, Chul-Su Yang
Journal of Microbiology and Biotechnology|October 4, 2019
Latest Comprehensive Knowledge of the Crosstalk between TLR Signaling and Mycobacteria and the Antigens Driving the ProcessJae-Sung Kim, Ye-Ram Kim, Chul-Su Yang
International Neurourology Journal|April 14, 2012
The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory DiseasesChul-Su Yang, Dong-Min Shin, Eun-Kyeong Jo
Immune Network|January 29, 2010
The role of nitric oxide in mycobacterial infectionsChul-Su Yang, Jae-Min Yuk, Eun-Kyeong Jo
Frontiers in Immunology|September 9, 2020
Host-Directed Therapy in Tuberculosis: Targeting Host MetabolismJae-Sung Kim, Ye-Ram Kim, Chul-Su Yang
Frontiers in Immunology|November 7, 2022
The strategies of NLRP3 inflammasome to combat <i>Toxoplasma gondii</i>Chanjin Yoon, Yu Seong Ham, Woo Jin Gil, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2022
Pathogen-derived peptides in drug targeting and its therapeutic approachSeok-Jun Mun, Euni Cho, Jae-Sung Kim, et al.
Pageof 10